Home/Filings/4/0001562180-23-004626
4//SEC Filing

Winters Chad 4

Accession 0001562180-23-004626

CIK 0000105770other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 4:37 PM ET

Size

11.3 KB

Accession

0001562180-23-004626

Insider Transaction Report

Form 4
Period: 2023-05-30
Winters Chad
VP, Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-05-30$143.43/sh+872$125,0712,320.711 total
  • Exercise/Conversion

    Common Stock

    2023-05-30$339.51/sh872$296,0531,448.711 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2023-05-30872456 total
    Exercise: $143.43From: 2020-10-29Exp: 2029-10-29Common Stock (872 underlying)

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001811424

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:37 PM ET
Size
11.3 KB